The Electrocardiogram (ECG) Devices Market, estimated at USD 6,440.4 Mn in 2025, is expected to exhibit a CAGR of 4.1% and reach USD 8,532.3 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Market Statistics:
The global Electrocardiogram (ECG) Devices Market is estimated to account for US$ 6,440.4 Mn in terms of value by the end of 2025.
Drivers:
Rise in burden of cardiovascular disease (CVDs) and growing geriatric population across the globe is expected to propel the growth of the global Electrocardiogram (ECG) Devices Market during the forecast period. For instance, an electrocardiogram (ECG) records the electrical signal from the heart to check for different heart conditions. ECG is an integral part of the initial evaluation of a patient suspected of having a cardiac-related problem. ECG is often used alongside other tests to diagnose and monitor conditions affecting the heart. According to the Centers for Disease Control and Prevention (CDC), heart disease is the leading cause of death in the United States. One person dies every 33 seconds in the United States from cardiovascular disease.
Opportunities:
High demand for technologically advanced, portable ECG monitors is expected to offer significant growth opportunities for players in the global Electrocardiogram (ECG) Devices Market. In October 2025, Dozee, planned to launch an ambulatory ECG patch to monitor patients with CVDs. The patch augments Dozee’s current artificial intelligence (AI)-powered RPM system to play a vital role in assisting healthcare professionals (HCPs) in identifying early signs of cardiac deterioration ensuring there is timely medical intervention, thereby improving patient safety. The ECG patch is small, flexible, light and convenient to use and physicians can remotely get alerts and view the live and continuous ECG of the patient from anywhere as the system is cloud-enabled.
Restraints:
High cost of instrument and high cost of maintenance is expected to hamper growth of the global Electrocardiogram (ECG) Devices Market. Approximately one-third of the problems reported with ECG devices arise from problems caused by the user, which is attributed to the lack of special knowledge about the equipment. For instance, 80% of reported ECG problems are due to misuse of the ECG machine by the operators, with improper training, which creates the burden of repair and maintenance. The high maintenance and upfront costs may force doctors to use traditional ECG devices instead of the latest high-end devices owing to the cost-effectiveness. This in turn expected to restrain growth of the global Electrocardiogram (ECG) Devices Market.
COVID-19 Impact Analysis:
Individuals with heart disease have been, and continue to be, at higher risk of developing severe COVID-19, according to the Centers for Disease Control and Prevention. The increase in the cases of cardiovascular complications due to COVID-19 increased the use of diagnostic ECG. ECG is a non-invasive test used at the bedside to help diagnosis and management of cardiac damage in the face of the COVID-19 pandemic and limited healthcare resources. These advantages and/or easy access to ECG in hospitals and emergency care during pandemic is expected to augment the growth of the global Electrocardiogram (ECG) Devices Market.